Zobrazeno 1 - 10
of 1 033
pro vyhledávání: '"A D, Seftel"'
Autor:
Gaganvir Parmar, Matthew D. Seftel, Kathy Ganz, John Blake, Jelena L. Holovati, David S. Allan
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2542-2551 (2024)
HLA-matched allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for many patients. Unrelated HLA-matched donors are the most frequently used donor for HCT. When more than one donor transplant option is available, transplant cent
Externí odkaz:
https://doaj.org/article/bdbbfe70cb714175b7d81199639e5cef
Autor:
Matthew D. Seftel, Ivan Pasic, Gaganvir Parmar, Oliver Bucher, David S. Allan, Sita Bhella, Kevin Anthony Hay, Oluwaseun Ikuomola, Grace Musto, Anca Prica, Erin Richardson, Tony H. Truong, Kristjan Paulson
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9953-9967 (2023)
Background: Hematopoietic cell transplantation (HCT) is an established therapy for hematologic malignancies and serious non-malignant blood disorders. Despite its curative potential, HCT is associated with substantial toxicity and health resource uti
Externí odkaz:
https://doaj.org/article/68837b5ed0774b23892c3c247e8b55e7
Autor:
Gaganvir Parmar, David S. Allan, Gail Morris, Nicholas Dibdin, Kathy Ganz, Karen Mostert, Kristjan Paulson, Tanya Petraszko, Nora Stevens, Matthew D. Seftel
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3549-3556 (2023)
Background and Objectives: The COVID-19 pandemic profoundly influenced unrelated donor (UD) allogeneic peripheral blood stem cell (PBSC) collections. Changes included efforts to minimize COVID-19 exposure to donors and cryopreservation of products. T
Externí odkaz:
https://doaj.org/article/2acbf848b34347f09154d46f207e0b89
Autor:
Gaganvir Parmar, Meagan Green, Karen Mostert, Tiffany Lawless, Nicholas Dibdin, Jason Weiss, Kathy Ganz, Tanya Petraszko, Matthew D. Seftel, David S. Allan
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9572-9581 (2022)
Background: The Canadian Blood Services Cord Blood Bank (CBS CBB) was created to improve access to stem cell products for transplantation for patients across ethnic groups. An analysis of distributed units is needed to assess the effectiveness of the
Externí odkaz:
https://doaj.org/article/69f3418f9b9e494289f0fcef7fde846a
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 2021-2045 (2022)
For patients with Mantle Cell Lymphoma (MCL), there is no recognized standard of care for relapsed/refractory (R/R) disease after treatment with a Bruton’s tyrosine kinase inhibitor (BTKi). Brexucabtagene autoleucel (brexu-cel) represents a promisi
Externí odkaz:
https://doaj.org/article/9255f991186e4344b4d4326cfda308c6
Publikováno v:
Transfusion. 63:1060-1066
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b6ecfc65b999fcddc00d9e65f713743
https://doi.org/10.1111/trf.17310
https://doi.org/10.1111/trf.17310
Publikováno v:
American Journal of Men's Health, Vol 12 (2018)
Men with hypogonadism (HG) who choose testosterone replacement therapy (TRT) may have distinct characteristics that provide insight as to why they may/may not initiate therapy. The aim of the current study was to identify trends in patient characteri
Externí odkaz:
https://doaj.org/article/f11685d78c324836b2bb78f9d2aa7ffe
Publikováno v:
American Journal of Men's Health, Vol 12 (2018)
This study evaluated the effect of axillary administration of a 2% testosterone solution (Axiron ® ) in hypogonadal (HGN) men who had had a suboptimal response to treatment with a commercially available topical testosterone gel. HGN men averaging 57
Externí odkaz:
https://doaj.org/article/cb00fcd0a9e04bfbae8d727fde5aded7
Publikováno v:
CMAJ : Canadian Medical Association Journal
[Voir la version anglaise de l’article ici: www.cmaj.ca/lookup/doi/10.1503/cmaj.202907][1] Points cles L’immunotherapie cellulaire est un traitement novateur qui fait appel aux proprietes anticancereuses des cellules immunitaires du corps. L’un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271aedae8724a3860a5f98fd197f0de9
https://doi.org/10.1503/cmaj.202907-f
https://doi.org/10.1503/cmaj.202907-f
Publikováno v:
CMAJ : Canadian Medical Association Journal
KEY POINTS Cellular immunotherapy is a novel therapy where the body’s own immune cells are harnessed for their anticancer effect. One of the most exciting of these approaches is chimeric antigen receptor T-cell therapy (CAR-T). This therapy is now
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901e9f3044293bf6909d4d332f59384c
https://doi.org/10.1503/cmaj.202907
https://doi.org/10.1503/cmaj.202907